S&P 500   2,997.29 (+1.05%)
DOW   27,030.30 (+0.91%)
QQQ   193.30 (+1.16%)
AAPL   236.02 (+0.06%)
FB   189.01 (+3.13%)
MSFT   141.47 (+1.38%)
GOOGL   1,241.32 (+1.93%)
AMZN   1,757.66 (+1.22%)
NVDA   198.30 (+6.31%)
MU   46.33 (+3.28%)
GE   8.90 (+1.95%)
TSLA   259.43 (+0.96%)
AMD   30.65 (+0.39%)
F   9.08 (+2.83%)
NFLX   284.47 (-0.37%)
BAC   30.12 (+3.36%)
GILD   65.66 (+1.77%)
S&P 500   2,997.29 (+1.05%)
DOW   27,030.30 (+0.91%)
QQQ   193.30 (+1.16%)
AAPL   236.02 (+0.06%)
FB   189.01 (+3.13%)
MSFT   141.47 (+1.38%)
GOOGL   1,241.32 (+1.93%)
AMZN   1,757.66 (+1.22%)
NVDA   198.30 (+6.31%)
MU   46.33 (+3.28%)
GE   8.90 (+1.95%)
TSLA   259.43 (+0.96%)
AMD   30.65 (+0.39%)
F   9.08 (+2.83%)
NFLX   284.47 (-0.37%)
BAC   30.12 (+3.36%)
GILD   65.66 (+1.77%)
Log in

Neogen Stock Price, News & Analysis (NASDAQ:NEOG)

$65.12
+1.26 (+1.97 %)
(As of 10/15/2019 12:27 PM ET)
Today's Range
$64.60
Now: $65.12
$65.40
50-Day Range
$62.61
MA: $69.78
$79.19
52-Week Range
$50.60
Now: $65.12
$79.83
Volume2,402 shs
Average Volume281,444 shs
Market Capitalization$3.41 billion
P/E Ratio56.69
Dividend YieldN/A
Beta1.4
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:NEOG
CUSIP64049110
Phone517-372-9200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$414.19 million
Cash Flow$1.52 per share
Book Value$12.24 per share

Profitability

Net Income$60.18 million

Miscellaneous

Employees1,682
Market Cap$3.41 billion
Next Earnings Date12/19/2019 (Estimated)
OptionableOptionable

Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.


Neogen (NASDAQ:NEOG) Frequently Asked Questions

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

When did Neogen's stock split? How did Neogen's stock split work?

Neogen's stock split on the morning of Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were issued to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

How will Neogen's stock buyback program work?

Neogen declared that its board has initiated a stock buyback program on Wednesday, October 10th 2018, which permits the company to repurchase 3,000,000 outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's management believes its shares are undervalued.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) issued its earnings results on Tuesday, September, 24th. The company reported $0.28 EPS for the quarter, missing analysts' consensus estimates of $0.29 by $0.01. The business earned $101.42 million during the quarter, compared to analyst estimates of $105.16 million. Neogen had a return on equity of 9.46% and a net margin of 14.32%. Neogen's revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period last year, the company earned $0.29 earnings per share. View Neogen's Earnings History.

When is Neogen's next earnings date?

Neogen is scheduled to release their next quarterly earnings announcement on Thursday, December 19th 2019. View Earnings Estimates for Neogen.

What price target have analysts set for NEOG?

3 equities research analysts have issued twelve-month price targets for Neogen's shares. Their forecasts range from $78.00 to $78.00. On average, they anticipate Neogen's share price to reach $78.00 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price. View Analyst Price Targets for Neogen.

What is the consensus analysts' recommendation for Neogen?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Neogen.

Has Neogen been receiving favorable news coverage?

News coverage about NEOG stock has been trending somewhat negative on Tuesday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Neogen earned a coverage optimism score of -1.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Neogen.

Are investors shorting Neogen?

Neogen saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 3,220,000 shares, an increase of 5.9% from the August 30th total of 3,040,000 shares. Based on an average daily volume of 239,000 shares, the days-to-cover ratio is presently 13.5 days. Approximately 6.2% of the company's stock are sold short. View Neogen's Current Options Chain.

Who are some of Neogen's key competitors?

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include WP Carey (WPC), JPMorgan Chase & Co. (JPM), GW Pharmaceuticals PLC- (GWPH), NVIDIA (NVDA), Boeing (BA), Edwards Lifesciences (EW), Nike (NKE), Pfizer (PFE), AT&T (T) and Celgene (CELG).

Who are Neogen's key executives?

Neogen's management team includes the folowing people:
  • Mr. James L. Herbert, Exec. Chairman (Age 79)
  • Mr. John Edward Adent, CEO & Pres (Age 51)
  • Mr. Steven J. Quinlan, VP, CFO & Sec. (Age 57)
  • Ms. Terri A. Morrical, VP of Animal Safety Operations (Age 54)
  • Mr. Rod Poland, Director of Corp. Communications

Who are Neogen's major shareholders?

Neogen's stock is owned by many different of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (2.40%), Private Trust Co. NA (0.09%), State of Alaska Department of Revenue (0.08%), We Are One Seven LLC (0.01%), Hardy Reed LLC (0.01%) and Gradient Investments LLC (0.00%). Company insiders that own Neogen stock include Edward Bradley, G Bruce Papesh, Jack C Parnell, James L Herbert, James P Tobin, John Edward Adent, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Institutional Ownership Trends for Neogen.

Which major investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including Private Trust Co. NA. Company insiders that have sold Neogen company stock in the last year include Jack C Parnell, James L Herbert, John Edward Adent, Steven J Quinlan, Terri A Morrical and William T Boehm. View Insider Buying and Selling for Neogen.

Which major investors are buying Neogen stock?

NEOG stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, State of Alaska Department of Revenue, We Are One Seven LLC, Hardy Reed LLC and Gradient Investments LLC. Company insiders that have bought Neogen stock in the last two years include James P Tobin and John Edward Adent. View Insider Buying and Selling for Neogen.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $65.12.

How big of a company is Neogen?

Neogen has a market capitalization of $3.41 billion and generates $414.19 million in revenue each year. The company earns $60.18 million in net income (profit) each year or $1.15 on an earnings per share basis. Neogen employs 1,682 workers across the globe.View Additional Information About Neogen.

What is Neogen's official website?

The official website for Neogen is http://www.neogen.com/.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at 517-372-9200 or via email at [email protected]


MarketBeat Community Rating for Neogen (NASDAQ NEOG)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  288 (Vote Outperform)
Underperform Votes:  392 (Vote Underperform)
Total Votes:  680
MarketBeat's community ratings are surveys of what our community members think about Neogen and other stocks. Vote "Outperform" if you believe NEOG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEOG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel